| Year |
Citation |
Score |
| 2024 |
Mittl K, Hayashi F, Dandekar R, Schubert RD, Gerdts J, Oshiro L, Loudermilk R, Greenfield A, Augusto DG, Ramesh A, Tran E, Koshal K, Kizer K, Dreux J, Cagalingan A, ... ... Moore T, et al. Antigen-specificity of clonally-enriched CD8+ T cells in multiple sclerosis. Biorxiv : the Preprint Server For Biology. PMID 39282370 DOI: 10.1101/2024.09.07.611010 |
0.473 |
|
| 2023 |
Kohlhapp FJ, O'Sullivan JA, Moore TV, Zloza A, Guevara-Patiño JA. NKG2D signaling shifts the balance of CD8 T cells from single cytokine- to polycytokine-producing effector cells. Molecular Immunology. 155: 1-6. PMID 36634520 DOI: 10.1016/j.molimm.2022.12.013 |
0.591 |
|
| 2021 |
Wang SY, Moore TV, Dalheim AV, Scurti GM, Nishimura MI. Melanoma reactive TCR-modified T cells generated without activation retain a less differentiated phenotype and mediate a superior in vivo response. Scientific Reports. 11: 13327. PMID 34172810 DOI: 10.1038/s41598-021-92808-6 |
0.474 |
|
| 2021 |
Moore TV, Scurti GM, DeJong M, Wang SY, Dalheim AV, Wagner CR, Hutchens KA, Speiser JJ, Godellas CV, Fountain C, Fleser J, Moudgil T, Thomas M, Murray D, Curti BD, et al. HDAC inhibition prevents transgene expression downregulation and loss-of-function in T-cell-receptor-transduced T cells. Molecular Therapy Oncolytics. 20: 352-363. PMID 33614916 DOI: 10.1016/j.omto.2021.01.014 |
0.507 |
|
| 2018 |
Foley KC, Nishimura MI, Moore TV. Combination immunotherapies implementing adoptive T-cell transfer for advanced-stage melanoma. Melanoma Research. PMID 29521881 DOI: 10.1097/Cmr.0000000000000436 |
0.348 |
|
| 2017 |
Moore T, Wagner CR, Scurti GM, Hutchens KA, Godellas C, Clark AL, Kolawole EM, Hellman LM, Singh NK, Huyke FA, Wang SY, Calabrese KM, Embree HD, Orentas R, Shirai K, et al. Correction to: Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells. Cancer Immunology, Immunotherapy : Cii. PMID 29264697 DOI: 10.1007/S00262-017-2102-Z |
0.407 |
|
| 2017 |
Moore T, Wagner CR, Scurti GM, Hutchens KA, Godellas C, Clark AL, Kolawole EM, Hellman LM, Singh NK, Huyke FA, Wang SY, Calabrese KM, Embree HD, Orentas R, Shirai K, et al. Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells. Cancer Immunology, Immunotherapy : Cii. PMID 29052782 DOI: 10.1007/S00262-017-2073-0 |
0.568 |
|
| 2017 |
Hrusch CL, Manns ST, Bryazka D, Casaos J, Bonham CA, Jaffery MR, Blaine KM, Mills KAM, Verhoef PA, Adegunsoye AO, Williams JW, Tjota MY, Moore TV, Strek ME, Noth I, et al. ICOS protects against mortality from acute lung injury through activation of IL-5(+) ILC2s. Mucosal Immunology. PMID 28488693 DOI: 10.1038/Mi.2017.42 |
0.613 |
|
| 2015 |
Regan C, Clark J, Moore T, Moxley K, Scurti G, Lau Clark A, Dropulic B, Embree H, Shirai K, Garrett-Mayer E, Li M, Tobin Vealey K, Eby JM, Le Poole C, Nishimura M. T-cell therapy in metastatic melanoma: TIL 1383I TCR transduced T cells after infusion and activity in vivo. Journal of Clinical Oncology. 33: 3043-3043. DOI: 10.1200/Jco.2015.33.15_Suppl.3043 |
0.465 |
|
| 2014 |
Chen B, Moore TV, Li Z, Sperling AI, Zhang C, Andrade J, Rodriguez A, Bahroos N, Huang Y, Morrisey EE, Gruber PJ, Solway J. Gata5 deficiency causes airway constrictor hyperresponsiveness in mice. American Journal of Respiratory Cell and Molecular Biology. 50: 787-95. PMID 24199649 DOI: 10.1165/Rcmb.2013-0294Oc |
0.653 |
|
| 2013 |
Williams JW, Yau D, Sethakorn N, Kach J, Reed EB, Moore TV, Cannon J, Jin X, Xing H, Muslin AJ, Sperling AI, Dulin NO. RGS3 controls T lymphocyte migration in a model of Th2-mediated airway inflammation. American Journal of Physiology. Lung Cellular and Molecular Physiology. 305: L693-701. PMID 24077945 DOI: 10.1152/Ajplung.00214.2013 |
0.763 |
|
| 2013 |
Wu Q, Gardiner GJ, Berry E, Wagner SR, Lu T, Clay BS, Moore TV, Ferreira CM, Williams JW, Luster AD, Medoff BD, Cannon JL, Sperling AI, Shilling RA. ICOS-expressing lymphocytes promote resolution of CD8-mediated lung injury in a mouse model of lung rejection. Plos One. 8: e72955. PMID 23967339 DOI: 10.1371/Journal.Pone.0072955 |
0.801 |
|
| 2012 |
Kohlhapp FJ, Zloza A, O'Sullivan JA, Moore TV, Lacek AT, Jagoda MC, McCracken J, Cole DJ, Guevara-Patiño JA. CD8(+) T cells sabotage their own memory potential through IFN-γ-dependent modification of the IL-12/IL-15 receptor α axis on dendritic cells. Journal of Immunology (Baltimore, Md. : 1950). 188: 3639-47. PMID 22430740 DOI: 10.4049/Jimmunol.1101580 |
0.628 |
|
| 2012 |
Zloza A, Kohlhapp FJ, Lyons GE, Schenkel JM, Moore TV, Lacek AT, O'Sullivan JA, Varanasi V, Williams JW, Jagoda MC, Bellavance EC, Marzo AL, Thomas PG, Zafirova B, Poli? B, et al. NKG2D signaling on CD8⁺ T cells represses T-bet and rescues CD4-unhelped CD8⁺ T cell memory recall but not effector responses. Nature Medicine. 18: 422-8. PMID 22366950 DOI: 10.1038/Nm.2683 |
0.776 |
|
| 2011 |
Zloza A, Lyons GE, Chlewicki LK, Kohlhapp FJ, O'Sullivan JA, Lacek AT, Moore TV, Jagoda MC, Kumar V, Guevara-Patiño JA. Engagement of NK receptor NKG2D, but not 2B4, results in self-reactive CD8+ T cells and autoimmune vitiligo. Autoimmunity. 44: 599-606. PMID 21913803 DOI: 10.3109/08916934.2011.593599 |
0.634 |
|
| 2011 |
O'Sullivan JA, Zloza A, Kohlhapp FJ, Moore TV, Lacek AT, Dulin NO, Guevara-Patiño JA. Priming with very low-affinity peptide ligands gives rise to CD8(+) T-cell effectors with enhanced function but with greater susceptibility to transforming growth factor (TGF)β-mediated suppression. Cancer Immunology, Immunotherapy : Cii. 60: 1543-51. PMID 21681376 DOI: 10.1007/S00262-011-1043-1 |
0.589 |
|
| 2011 |
Moore TV, Clay BS, Cannon JL, Histed A, Shilling RA, Sperling AI. Inducible costimulator controls migration of T cells to the lungs via down-regulation of CCR7 and CD62L American Journal of Respiratory Cell and Molecular Biology. 45: 843-850. PMID 21421907 DOI: 10.1165/Rcmb.2010-0466Oc |
0.847 |
|
| 2011 |
Moore TV, Clay BS, Ferreira CM, Williams JW, Rogozinska M, Cannon JL, Shilling RA, Marzo AL, Sperling AI. Protective effector memory CD4 T cells depend on ICOS for survival. Plos One. 6: e16529. PMID 21364749 DOI: 10.1371/Journal.Pone.0016529 |
0.835 |
|
| 2011 |
Cannon JL, Mody PD, Blaine KM, Chen EJ, Nelson AD, Sayles LJ, Moore TV, Clay BS, Dulin NO, Shilling RA, Burkhardt JK, Sperling AI. CD43 interaction with ezrin-radixin-moesin (ERM) proteins regulates T-cell trafficking and CD43 phosphorylation. Molecular Biology of the Cell. 22: 954-63. PMID 21289089 DOI: 10.1091/Mbc.E10-07-0586 |
0.774 |
|
| 2010 |
Tong J, Clay BS, Ferreira CM, Bandukwala HS, Moore TV, Blaine KM, Williams JW, Hoffman LM, Hamann KJ, Shilling RA, Weinstock JV, Sperling AI. Fas ligand expression on T cells is sufficient to prevent prolonged airway inflammation in a murine model of asthma. American Journal of Respiratory Cell and Molecular Biology. 43: 342-8. PMID 19855087 DOI: 10.1165/Rcmb.2008-0454Oc |
0.784 |
|
| 2009 |
Clay BS, Shilling RA, Bandukwala HS, Moore TV, Cannon JL, Welcher AA, Weinstock JV, Sperling AI. Inducible costimulator expression regulates the magnitude of Th2-mediated airway inflammation by regulating the number of Th2 cells. Plos One. 4: e7525. PMID 19888475 DOI: 10.1371/Journal.Pone.0007525 |
0.776 |
|
| 2009 |
Shilling RA, Clay BS, Tesciuba AG, Berry EL, Lu T, Moore TV, Bandukwala HS, Tong J, Weinstock JV, Flavell RA, Horan T, Yoshinaga SK, Welcher AA, Cannon JL, Sperling AI. CD28 and ICOS play complementary non-overlapping roles in the development of Th2 immunity in vivo. Cellular Immunology. 259: 177-84. PMID 19646680 DOI: 10.1016/J.Cellimm.2009.06.013 |
0.705 |
|
| 2009 |
Voelkl S, Moore TV, Rehli M, Nishimura MI, Mackensen A, Fischer K. Characterization of MHC class-I restricted TCRalphabeta+ CD4- CD8- double negative T cells recognizing the gp100 antigen from a melanoma patient after gp100 vaccination. Cancer Immunology, Immunotherapy : Cii. 58: 709-18. PMID 18836718 DOI: 10.1007/S00262-008-0593-3 |
0.612 |
|
| 2009 |
Moore TV, Lyons GE, Brasic N, Roszkowski JJ, Voelkl S, Mackensen A, Kast WM, Le Poole IC, Nishimura MI. Relationship between CD8-dependent antigen recognition, T cell functional avidity, and tumor cell recognition. Cancer Immunology, Immunotherapy : Cii. 58: 719-28. PMID 18836717 DOI: 10.1007/S00262-008-0594-2 |
0.604 |
|
| 2008 |
Tesciuba AG, Shilling RA, Agarwal MD, Bandukwala HS, Clay BS, Moore TV, Weinstock JV, Welcher AA, Sperling AI. ICOS costimulation expands Th2 immunity by augmenting migration of lymphocytes to draining lymph nodes. Journal of Immunology (Baltimore, Md. : 1950). 181: 1019-24. PMID 18606653 DOI: 10.4049/Jimmunol.181.2.1019 |
0.694 |
|
| 2008 |
Voelkl S, Moore T, Rehli M, Nishimura M, Fischer K, Mackensen A. Characterization of MHC Class-I Restricted TCRαβ+CD4−CD8− Double-Negative T Cells Recognizing the gp100 Antigen from a Melanoma Patient after gp100 Vaccination Blood. 112: 4905-4905. DOI: 10.1182/Blood.V112.11.4905.4905 |
0.598 |
|
| 2006 |
Lyons GE, Moore T, Brasic N, Li M, Roszkowski JJ, Nishimura MI. Influence of human CD8 on antigen recognition by T-cell receptor-transduced cells. Cancer Research. 66: 11455-61. PMID 17145893 DOI: 10.1158/0008-5472.Can-06-2379 |
0.602 |
|
| 2006 |
Callender GG, Rosen HR, Roszkowski JJ, Lyons GE, Li M, Moore T, Brasic N, McKee MD, Nishimura MI. Identification of a hepatitis C virus-reactive T cell receptor that does not require CD8 for target cell recognition. Hepatology (Baltimore, Md.). 43: 973-81. PMID 16628627 DOI: 10.1002/Hep.21157 |
0.466 |
|
| 2005 |
Nishimura MI, Roszkowski JJ, Moore TV, Brasic N, McKee MD, Clay TM. Antigen recognition and T-cell biology. Cancer Treatment and Research. 123: 37-59. PMID 16211865 DOI: 10.1007/0-387-27545-2_2 |
0.496 |
|
| 2005 |
Kaplan BL, Moore TV, Schreiber K, Callender GG, Schreiber H, Nishimura MI. A new murine tumor model for studying HLA-A2-restricted anti-tumor immunity. Cancer Letters. 224: 153-66. PMID 15911111 DOI: 10.1016/J.Canlet.2004.11.035 |
0.3 |
|
| Show low-probability matches. |